Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Target Therapy: A Single-Center Experience
This study provides evidence that RD SRS could offer reduced toxicity rates, while maintaining high local control as compared with the current guideline-SDs for the treatment of melanoma brain metastases.
Authors
- Jason Sheehan (ORCID: https://orcid.org/0000-0002-0025-9886)
- Chloé Dumot (ORCID: https://orcid.org/0000-0003-1333-2533)
- Stylianos Pikis (ORCID: https://orcid.org/0000-0002-2020-7653)
- Salem M Tos (ORCID: https://orcid.org/0000-0001-7154-6869)
- Ahmed A. Shaaban (ORCID: https://orcid.org/0000-0002-5850-9569)
- Georgios Mantziaris (ORCID: https://orcid.org/0000-0002-3389-8836)
Institutions
- Hospices Civils de Lyon (FR)
- Neurological Surgery (US)
- University of Virginia (US)
Publication Details
- Journal
- Neurosurgery
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1227/neu.0000000000003239
- Citations
- 3
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26